Pain Therapeutics Inc (PTIE)

Trade PTIE now with
3/27/2019 8:38:20 AM Pain Therapeutics Announces Company Name Change To Cassava Sciences
3/25/2019 8:36:37 AM Pain Therapeutics FY Net Loss $6.6 Mln Or $0.61/Shr Vs Loss $11.9 Mln Or $1.82/Shr Last Year
2/5/2019 8:10:42 AM Pain Therapeutics Announces Feedback From Recent Meeting With FDA On REMOXY
12/6/2018 7:33:01 AM Pain Therapeutics Unveils Initiation Of Phase II Study In Alzheimer’s Disease
11/12/2018 7:32:23 AM Pain Therapeutics Appeals FDA Decision On REMOXY; FDA Agrees To Meet In-person On January 31
10/11/2018 7:31:08 AM Pain Therapeutics Names Eric Schoen CFO
8/16/2018 7:11:43 AM Pain Therapeutics Announces $11.3 Mln Registered Direct Offering Priced At-the-Market
8/15/2018 8:07:33 AM Pain Therapeutics Receives $3.2 Mln NIH Grant To Study Alzheimer’s Disease
8/6/2018 9:22:49 AM DURECT's Licensee Pain Therapeutics Gets Complete Response Letter From FDA For REMOXY ER Extended-Release Capsules CII
6/26/2018 8:34:34 PM DURECT Says FDA Advisory Committee Votes 14 To 3 Against Approval Of REMOXY